$DYN

$16.94 +$1.22 (7.76%) Close

$DYN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$DYN Management Team

Mrs. Amy Reilly

Senior Vice President - Corporate Communications and Investor Relations

Age -

Compensation -

Sex Female

Mr. Erick Lucera

Chief Financial Officer

Treasurer

Age 57

Compensation -

Sex Male

Dr. Ranjan Batra

Chief Scientific Officer

Age -

Compensation -

Sex Male

Dr. Doug Kerr

Chief Medical Officer

Age 58

Compensation $7.742M USD

Sex Male

Dr. Vikram Ranade

Chief Business Officer

Age -

Compensation -

Sex Male

Mr. Jason Rhodes

Independent Chairman of the Board

Age 56

Compensation $579.8K USD

Sex Male

Mr. John Cox

President

Chief Executive Officer

Director

Age 62

Compensation $20.69M USD

Sex Male

Dr. Oxana Beskrovnaya

Chief Innovation Officer

Age 64

Compensation $3.836M USD

Sex Female

Ms. Johanna Friedl- Naderer

Chief Commercial Officer

Age 57

Compensation $8.190M USD

Sex Female

Name / Title	Age	Compensation	Sex
Mrs. Amy Reilly Senior Vice President - Corporate Communications and Investor Relations	-	-	Female
Mr. Erick Lucera Chief Financial Officer Treasurer	57	-	Male
Dr. Ranjan Batra Chief Scientific Officer	-	-	Male
Dr. Doug Kerr Chief Medical Officer	58	$7.742M USD	Male
Dr. Vikram Ranade Chief Business Officer	-	-	Male
Mr. Jason Rhodes Independent Chairman of the Board	56	$579.8K USD	Male
Mr. John Cox President Chief Executive Officer Director	62	$20.69M USD	Male
Dr. Oxana Beskrovnaya Chief Innovation Officer	64	$3.836M USD	Female
Ms. Johanna Friedl- Naderer Chief Commercial Officer	57	$8.190M USD	Female

Board of Directors

From the proxy statement filed Apr 23, 2026

Directors

serving now

Independent

0 of 1

stated in the proxy; 8 not stated

Average tenure

5.1 years

from year joined

CEO also chairs the board

Jason Rhodes

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Carlo Incerti	67	2022 4 years	Not stated	Research and Development Committee	None stated	$317,006
Catherine Stehman-Breen	63	2019 7 years	Not stated	None stated	Tenaya Therapeutics, Inc.	$327,006
John G. Cox CEO	63	2024 2 years	Not independent	None stated	None stated	Paid as CEO
Edward Hurwitz	62	2018 8 years	Not stated	Compensation Committee	MacroGenics, Inc.	$317,006
Vikram Karnani	51	2025 1 year	Not stated	None stated	Collegium Pharmaceutical, Inc.	$798,986
Dirk Kersten	51	2018 8 years	Not stated	Compensation Committee · Chair	None stated	$334,506
David Lubner	61	2020 6 years	Not stated	Audit Committee · Chair	Arcellx Inc., Crescent Biopharma, Inc.	$334,506
Brian Posner	64	2025 1 year	Not stated	None stated	Arch Capital Group Ltd.	$571,159
Jason Rhodes Board chair	56	2017 9 years	Not stated	Nominating and Corporate Governance Committee · Chair	None stated	$354,506

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 23, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$DYN Management Team

Mrs. Amy Reilly

Mr. Erick Lucera

Dr. Ranjan Batra

Dr. Doug Kerr

Dr. Vikram Ranade

Mr. Jason Rhodes

Mr. John Cox

Dr. Oxana Beskrovnaya

Ms. Johanna Friedl- Naderer

Board of Directors

Related-party transactions

No related-party transactions disclosed